ACRV Acrivon Therapeutics, Inc. - Common Stock
$2,09
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 12, 2026
Rango 52S
$1–$4
36% of range
Calificación del Analista
BUY
14 analysts
Precio Objetivo
$12
+450% upside
P/E (TTM)
-1.0
ROE
-61.0%
Margen de Beneficio Neto
—
ACRV Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.09
Capitalización Bursátil
$66M
P/E (TTM)
-1.0
BPA (TTM)
$-2.02
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-61.0%
Deuda/Capital
—
Rango 52S
$1 – $4
ACRV Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-2.02
2021-12-31
→
2025-12-31
Flujo de caja libre
$-65M
2022-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ACRV
Mediana de Pares
P/E (TTM)
-1.0
4.7
P/B (P/C)
0.6
1.8
Price / FCF (Precio / FCF)
-1.0
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ACRV
Mediana de Pares
ROA
-47.8%
-68.1%
ROE
-61.0%
-111.7%
ROIC
-74.8%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ACRV
Mediana de Pares
Current Ratio (Ratio corriente)
7.7
4.1
Quick Ratio (Ratio Rápido)
7.6
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ACRV
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ACRV
Mediana de Pares
ACRV Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
14 analistas
- Compra fuerte 4 28,6%
- Compra 9 64,3%
- Mantener 1 7,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
6 analistas · 2026-08-15
Mediana
$10.50
Media
$11.50
← Por Debajo de Todos los Objetivos
$2.09
Mín
$7.00
Máx
$19.00
Objetivo mediano
$10.50
+402,2%
Objetivo medio
$11.50
+450,0%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.07%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.49 | $-0.54 | 0.05% |
| 31 de diciembre de 2025 | $-0.52 | $-0.48 | -0.04% |
| 30 de septiembre de 2025 | $-0.47 | $-0.60 | 0.13% |
| 30 de junio de 2025 | $-0.55 | $-0.60 | 0.05% |
| 31 de marzo de 2025 | $-0.51 | $-0.66 | 0.15% |
| 31 de diciembre de 2024 | $-0.60 | $-0.68 | 0.08% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ACRV | $76M | -1.2 | — | — | -61.0% | — |
| FBIO | — | — | — | — | — | — |
| ALDX | $312M | -9.2 | — | — | -68.0% | — |
| KLRS | $193M | -3.0 | — | — | -65.8% | — |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | — |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | — |
| ICCC | — | -51.2 | 4.3% | — | — | — |
| GANX | $135M | -5.3 | -60.6% | — | -181.1% | — |
| ACET | — | -0.5 | — | — | — | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $60M | $64M | $46M | $24M | · | |
| SG&A Expense | $24M | $25M | $21M | $9M | · | |
| Operating Expenses | $84M | $89M | $67M | $33M | $16M | |
| Operating Income | $-84M | $-89M | $-67M | $-33M | $-16M | |
| Interest Income | · | · | $7M | $2M | · | |
| Other Non-op | $-270.0K | $-558.0K | $-322.0K | $1M | $21.0K | |
| Pretax Income | $-78M | $-80M | · | · | · | |
| Income Tax | $0 | · | · | · | · | |
| Net Income | $-78M | $-81M | $-60M | $-31M | $-16M | |
| EPS (Basic) | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 | |
| EPS (Diluted) | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 | |
| Shares (Basic) | 38,509,281 | 33,791,817 | 22,078,190 | 4,121,912 | 1,743,382 | |
| Shares (Diluted) | 38,509,281 | 33,791,817 | 22,078,190 | 4,121,912 | 1,743,382 | |
| EBITDA | $-84M | $-89M | $-67M | $-33M | · |
Balance general 20
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $40M | $36M | $30M | $100M | |
| Short-term Investments | $77M | $140M | $91M | $98M | · | |
| Prepaid Expense | $2M | $2M | $2M | $4M | $805.0K | |
| Current Assets | $120M | $182M | $130M | $132M | $100M | |
| PP&E (Net) | $5M | $4M | $3M | $2M | $290.0K | |
| PP&E (Gross) | $8M | $6M | $4M | $3M | $346.0K | |
| Accum. Depreciation | $3M | $2M | $956.0K | $420.0K | $56.0K | |
| Other Non-current Assets | $2M | $2M | $251.0K | · | · | |
| Total Assets | $130M | $197M | $138M | $181M | $107M | |
| Accounts Payable | $2M | $758.0K | $5M | $904.0K | $964.0K | |
| Current Liabilities | $16M | $17M | $13M | $7M | $3M | |
| Capital Leases | $2M | $3M | $4M | $4M | $5M | |
| Total Liabilities | $17M | $20M | $17M | $11M | $8M | |
| Common Stock | $31.0K | $31.0K | $23.0K | $22.0K | $2.0K | |
| Paid-in Capital | $387M | $373M | $238M | $227M | $1M | |
| Retained Earnings | $-275M | $-197M | $-116M | $-56M | $-25M | |
| AOCI | $111.0K | $447.0K | $-83.0K | $-95.0K | · | |
| Stockholders' Equity | $113M | $177M | $121M | $170M | $-24M | |
| Liabilities + Equity | $130M | $197M | $138M | $181M | $107M | |
| Shares Outstanding | 31,648,856 | 31,231,264 | 22,522,644 | 21,920,402 | 1,769,561 |
Flujo de Efectivo 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $15M | $14M | $12M | $2M | $497.0K | |
| Operating Cash Flow | $-64M | $-66M | $-43M | $-30M | $-14M | |
| CapEx | $2M | $3M | $1M | $2M | $238.0K | |
| Investing Cash Flow | $66M | $-52M | $51M | $-142M | $-238.0K | |
| Financing Cash Flow | $-749.0K | $121M | $-2M | $102M | $112M | |
| Net Change in Cash | $2M | $4M | $7M | $-70M | $98M | |
| Free Cash Flow | $-65M | $-68M | $-44M | $-32M | · |
Rentabilidad 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -47.8% | -48.1% | -37.8% | -21.7% | · | |
| ROE | -61.0% | -43.1% | -46.6% | -49.9% | · | |
| ROIC | -74.8% | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 7.7 | 10.6 | 9.7 | 20.3 | · | |
| Quick Ratio | 7.6 | 10.4 | 9.6 | 19.6 | · |
Valoración (TTM) 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-78M | $-81M | $-60M | $-31M | · | |
| Market Cap | $76M | $188M | $111M | $253M | · | |
| P/E | -1.2 | -2.5 | -1.8 | -1.5 | · | |
| P/B | 0.7 | 1.1 | 0.9 | 1.5 | · | |
| P / Tangible Book | 0.7 | 1.1 | 0.9 | 1.5 | · | |
| P / Cash Flow | -1.2 | -2.9 | -2.6 | -8.4 | · | |
| P / FCF | -1.2 | -2.7 | -2.5 | -7.8 | · | |
| Earnings Yield | -83.8% | -39.5% | -55.7% | -65.6% | · |
Estado de resultados 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $15M | $15M | $14M | $16M | $15M | $19M | $19M | $15M | $11M | $15M | $10M | $11M | $10M | · | · | |
| SG&A Expense | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | · | · | |
| Operating Expenses | $19M | $20M | $20M | $20M | $23M | $22M | $25M | $25M | $21M | $18M | $21M | $16M | $16M | $14M | $10M | $10M | |
| Operating Income | $-19M | $-20M | $-20M | $-20M | $-23M | $-22M | $-25M | $-25M | $-21M | $-18M | $-21M | $-16M | $-16M | $-14M | $-10M | $-10M | |
| Other Non-op | $-156.0K | $-129.0K | $-116.0K | $-53.0K | $-87.0K | $-14.0K | $-240.0K | $1.0K | $-55.0K | $-264.0K | $109.0K | $-97.0K | $-164.0K | $-170.0K | $1M | $377.0K | |
| Net Income | $-18M | $-19M | $-19M | $-18M | $-21M | $-20M | $-23M | $-22M | $-19M | $-16M | $-19M | $-14M | $-14M | $-13M | $-9M | $-9M | |
| EPS (Basic) | $-0.43 | $-0.49 | $-0.49 | $-0.47 | $-0.55 | $-0.51 | $-0.54 | $-0.59 | $-0.52 | $-0.73 | $-0.87 | $-0.66 | $-0.63 | $-0.58 | $4.98 | $-5.17 | |
| EPS (Diluted) | $-0.43 | $-0.49 | $-0.49 | $-0.47 | $-0.55 | $-0.51 | $-0.54 | $-0.59 | $-0.52 | $-0.73 | $-0.87 | $-0.66 | $-0.63 | $-0.58 | $4.98 | $-5.17 | |
| Shares (Basic) | 41,841,887 | 38,724,803 | -76,863,246 | 38,560,464 | 38,461,619 | 38,350,444 | -63,036,734 | 38,105,131 | 36,132,616 | 22,590,804 | -43,894,574 | 22,081,162 | 21,971,032 | 21,920,570 | -1,195,465 | 1,778,255 | |
| Shares (Diluted) | 41,841,887 | 38,724,803 | -76,863,246 | 38,560,464 | 38,461,619 | 38,350,444 | -63,036,734 | 38,105,131 | 36,132,616 | 22,590,804 | -43,894,574 | 22,081,162 | 21,971,032 | 21,920,570 | -1,195,465 | 1,778,255 | |
| EBITDA | $-19M | $-20M | · | $-20M | $-23M | $-22M | · | $-25M | $-21M | $-18M | · | $-16M | $-16M | $-14M | · | $-10M |
Balance general 20
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $34M | $41M | $35M | $42M | $39M | $40M | $43M | $46M | $25M | $36M | $30M | $38M | $27M | $30M | $32M | |
| Short-term Investments | $49M | $64M | $77M | $94M | $96M | $110M | $140M | $144M | $135M | $85M | $91M | $112M | $113M | $93M | $98M | · | |
| Prepaid Expense | $2M | $1M | $2M | $1M | $989.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $2M | |
| Current Assets | $91M | $99M | $120M | $130M | $138M | $151M | $182M | $189M | $182M | $112M | $130M | $144M | $153M | $124M | $132M | $79M | |
| PP&E (Net) | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $8M | $8M | $8M | $8M | $8M | $7M | $6M | $6M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $956.0K | $807.0K | $674.0K | $545.0K | $420.0K | $295.0K | |
| Other Non-current Assets | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | · | $251.0K | · | · | · | · | · | |
| Total Assets | $99M | $108M | $130M | $145M | $159M | $176M | $197M | $215M | $231M | $121M | $138M | $151M | $160M | $170M | $181M | $88M | |
| Accounts Payable | $861.0K | $1M | $2M | $996.0K | $1M | $4M | $758.0K | $2M | $1M | $2M | $5M | $2M | $1M | $1M | $904.0K | $2M | |
| Current Liabilities | $11M | $11M | $16M | $15M | $13M | $14M | $17M | $15M | $11M | $9M | $13M | $9M | $7M | $6M | $7M | $6M | |
| Capital Leases | $980.0K | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Total Liabilities | $12M | $12M | $17M | $17M | $16M | $16M | $20M | $18M | $15M | $13M | $17M | $13M | $11M | $10M | $11M | $11M | |
| Common Stock | $42.0K | $38.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $23.0K | $23.0K | $22.0K | $22.0K | $22.0K | $22.0K | $2.0K | |
| Paid-in Capital | $399M | $389M | $387M | $384M | $381M | $377M | $373M | $370M | $368M | $241M | $238M | $236M | $232M | $229M | $227M | $2M | |
| Retained Earnings | $-312M | $-294M | $-275M | $-256M | $-238M | $-217M | $-197M | $-174M | $-152M | $-133M | $-116M | $-97M | $-83M | $-69M | $-56M | $-47M | |
| AOCI | $-33.0K | $4.0K | $111.0K | $112.0K | $106.0K | $283.0K | $447.0K | $782.0K | $-19.0K | $-70.0K | $-83.0K | $-302.0K | $-427.0K | $9.0K | $-95.0K | $-133.0K | |
| Stockholders' Equity | $87M | $96M | $113M | $129M | $143M | $160M | $177M | $197M | $216M | $108M | $121M | $138M | $149M | $160M | $170M | $-46M | |
| Liabilities + Equity | $99M | $108M | $130M | $145M | $159M | $176M | $197M | $215M | $231M | $121M | $138M | $151M | $160M | $170M | $181M | $88M | |
| Shares Outstanding | 42,847,215 | 38,745,032 | 31,648,856 | 31,549,770 | 31,449,744 | 31,352,067 | 31,231,264 | 31,130,892 | 30,966,255 | 22,637,539 | 22,522,644 | 22,104,469 | 22,068,660 | 21,920,634 | 21,920,402 | 1,794,600 |
Flujo de Efectivo 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $267.0K | |
| Operating Cash Flow | $-15M | $-21M | $-15M | $-12M | $-17M | $-20M | $-17M | $-17M | $-14M | $-17M | $-12M | $-10M | $-9M | $-11M | $-9M | $-7M | |
| CapEx | $87.0K | $14.0K | $219.0K | $899.0K | $493.0K | $58.0K | $827.0K | $989.0K | $137.0K | $815.0K | $1M | $0 | $112.0K | $25.0K | $251.0K | $426.0K | |
| Investing Cash Flow | $15M | $13M | $22M | $6M | $19M | $19M | $14M | $16M | $-88M | $6M | $21M | $2M | $19M | $9M | $-95M | $-45M | |
| Financing Cash Flow | $7M | $-33.0K | $-192.0K | $-117.0K | $-97.0K | $-343.0K | $-647.0K | $-2M | $123M | $-172.0K | $-2M | $78.0K | · | · | $102M | $-140.0K | |
| Net Change in Cash | $7M | $-7M | $6M | $-6M | $3M | $-664.0K | $-4M | $-3M | $21M | $-11M | $6M | $-8M | $11M | $-2M | $-3M | $-52M | |
| Free Cash Flow | · | $-21M | · | · | · | $-20M | · | · | · | $-18M | · | · | · | $-11M | · | · |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -13.9% | -13.4% | · | -10.1% | -10.8% | -13.3% | · | -12.3% | -9.6% | -11.3% | · | -12.1% | -17.4% | -15.0% | · | -21.0% | |
| ROE | -15.6% | -14.9% | · | -11.2% | -11.7% | -14.7% | · | -13.4% | -10.3% | -12.3% | · | -31.3% | -18.6% | -15.9% | · | 40.3% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 9.0 | · | 8.8 | 10.3 | 11.2 | · | 12.8 | 16.2 | 12.4 | · | 15.5 | 21.8 | 21.8 | · | 12.3 | |
| Quick Ratio | 7.9 | 8.8 | · | 8.7 | 10.2 | 11.0 | · | 12.6 | 16.0 | 12.2 | · | 15.3 | 21.5 | 21.2 | · | 5.0 |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-76M | $-78M | · | $-81M | $-82M | $-77M | · | $-72M | $-64M | $-58M | · | $-50M | $-42M | $-35M | · | $-25M | |
| Market Cap | $76M | $54M | · | $57M | $37M | $64M | · | $218M | $180M | $162M | · | $211M | $286M | $278M | · | · | |
| P/E | -0.9 | -0.7 | · | -0.9 | -0.5 | -0.9 | · | -2.8 | -2.3 | -2.8 | · | -1.4 | -1.3 | -1.0 | · | · | |
| P/B | 0.9 | 0.6 | · | 0.4 | 0.3 | 0.4 | · | 1.1 | 0.8 | 1.5 | · | 1.5 | 1.9 | 1.7 | · | · | |
| P / Tangible Book | 0.9 | 0.6 | · | 0.4 | 0.3 | 0.4 | · | 1.1 | 0.8 | 1.5 | · | 1.5 | 1.9 | 1.7 | · | · | |
| P / Cash Flow | · | -2.6 | · | · | · | -3.3 | · | · | · | -9.5 | · | · | · | -24.5 | · | · | |
| P / FCF | · | -2.6 | · | · | · | -3.2 | · | · | · | -9.0 | · | · | · | -24.4 | · | · | |
| Earnings Yield | -109.0% | -145.3% | · | -117.1% | -182.3% | -115.8% | · | -35.7% | -43.8% | -36.4% | · | -73.6% | -74.6% | -103.4% | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Beneficio neto | $-78M | $-81M | $-60M | $-31M | $-16M |
| EPS Diluido | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 7.7 | 10.6 | 9.7 | 20.3 | — |
| Ratio Rápido | 7.6 | 10.4 | 9.6 | 19.6 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-65M | $-68M | $-44M | $-32M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 49 declarantes · $36.5M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 8 (-2 vs trimestre anterior) | 4 (-8 vs trimestre anterior) | 15 (+6 vs trimestre anterior) | 7 (-3 vs trimestre anterior) | +5.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $21 768 325 | 12 229 396 | 59,72% | Acciones |
| Sands Capital Alternatives, LLC | $4 074 902 | 2 289 271 | 11,18% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 694 574 | 952 008 | 4,65% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 580 871 | 888 130 | 4,34% | Acciones |
| VANGUARD GROUP INC | $1 414 369 | 586 875 | 3,88% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 350 776 | 758 863 | 3,71% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 141 866 | 641 498 | 3,13% | Acciones |
| TWO SIGMA ADVISERS, LP | $804 393 | 333 773 | 2,21% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $674 442 | 378 900 | 1,85% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $399 619 | 224 424 | 1,10% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $327 748 | 184 128 | 0,90% | Acciones |
| XTX Topco Ltd | $317 265 | 178 239 | 0,87% | Acciones |
| NORTHERN TRUST CORP | $119 620 | 67 202 | 0,33% | Acciones |
| STATE STREET CORP | $119 518 | 67 145 | 0,33% | Acciones |
| JANE STREET GROUP, LLC | $117 845 | 66 205 | 0,32% | Acciones |
| CITADEL ADVISORS LLC | $73 471 | 41 276 | 0,20% | Acciones |
| UBS Group AG | $65 335 | 36 705 | 0,18% | Acciones |
| MARSHALL WACE, LLP | $60 160 | 33 798 | 0,17% | Acciones |
| Spark Investment Management LLC | $50 374 | 28 300 | 0,14% | Acciones |
| PRELUDE CAPITAL MANAGEMENT, LLC | $42 747 | 24 015 | 0,12% | Acciones |
| BANK OF AMERICA CORP /DE/ | $29 204 | 16 407 | 0,08% | Acciones |
| Verdad Advisers, LP | $26 796 | 15 054 | 0,07% | Acciones |
| GOLDMAN SACHS GROUP INC | $26 558 | 14 920 | 0,07% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $24 566 | 13 801 | 0,07% | Acciones |
| Squarepoint Ops LLC | $23 690 | 13 309 | 0,06% | Acciones |
| AAF Wealth Management, LLC | $19 007 | 10 678 | 0,05% | Acciones |
| BlackRock, Inc. | $18 873 | 10 603 | 0,05% | Acciones |
| Marex Group Ltd | $17 800 | 10 000 | 0,05% | Acciones |
| FEDERATED HERMES, INC. | $14 105 | 7 924 | 0,04% | Acciones |
| FMR LLC | $12 383 | 6 957 | 0,03% | Acciones |
| BARCLAYS PLC | $10 573 | 5 940 | 0,03% | Acciones |
| Nuveen Asset Management, LLC | $9 518 | 1 581 | 0,03% | Acciones |
| MORGAN STANLEY | $7 782 | 4 372 | 0,02% | Acciones |
| Tower Research Capital LLC (TRC) | $2 985 | 1 677 | 0,01% | Acciones |
| ACADIAN ASSET MANAGEMENT LLC | $2 073 | 1 165 119 | 0,01% | Acciones |
| Crews Bank & Trust | $1 858 | 1 044 | 0,01% | Acciones |
| NISA INVESTMENT ADVISORS, LLC | $1 040 | 584 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $956 | 537 | 0,00% | Acciones |
| Redwood Park Advisors LLC | $890 | 500 | 0,00% | Acciones |
| Russell Investments Group, Ltd. | $856 | 481 | 0,00% | Acciones |
| Federation des caisses Desjardins du Quebec | $712 | 400 | 0,00% | Acciones |
| Steward Partners Investment Advisory, LLC | $580 | 326 | 0,00% | Acciones |
| GSA CAPITAL PARTNERS LLP | $357 | 200 415 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $164 | 92 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $134 | 75 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $89 | 50 | 0,00% | Acciones |
| HRT FINANCIAL LP | $18 | 10 316 | 0,00% | Acciones |
| CITIGROUP INC | $11 | 6 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $0 | 30 | 0,00% | Acciones |
Informantes de la empresa 17 insiders · 9 directivos · 8 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Peter Blume-Jensen | President and CEO | 14 de agosto de 2024 F | 2 502 129 | 0 | 0 | $0 |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 1 de marzo de 2025 A | 26 088 | 0 | 0 | $0 |
| Eric Devroe | Chief Operating Officer | 18 de mayo de 2026 A | 146 953 | 1 | 0 | $17 200 |
| Mary Miller | Chief Legal Officer | 21 de julio de 2026 S | 82 194 | 0 | 1 | $-1 008 |
| Katharine Peterson | Chief Accounting Officer | 18 de mayo de 2026 A | 18 134 | 0 | 0 | $0 |
| Erick Gamelin | Chief Development Officer | 18 de mayo de 2026 A | 52 992 | 0 | 0 | $0 |
| Mansoor Raza Mirza | Chief Medical Officer | 18 de mayo de 2026 A | 38 817 | 0 | 0 | $0 |
| Jean-Marie Cuillerot | Chief Medical Officer | 1 de marzo de 2025 A | — | 0 | 0 | $0 |
| Kristina Masson | EVP - Business Operations | 14 de agosto de 2024 F | 317 246 | 0 | 0 | $0 |
| Santhosh Palani | Consejero | 17 de junio de 2026 A | 9 366 | 0 | 0 | $0 |
| Derek Dirocco | Consejero | 17 de junio de 2026 A | 9 366 | 0 | 0 | $0 |
| Sharon Shacham | Consejero | 17 de junio de 2026 A | 9 366 | 0 | 0 | $0 |
| Charles M Baum | Consejero | 17 de junio de 2026 A | 9 366 | 0 | 0 | $0 |
| Michael John Tomsicek | Consejero | 17 de junio de 2026 A | 9 366 | 0 | 0 | $0 |
| Ivana Magovcevic-Liebisch | Consejero | 17 de junio de 2026 A | 9 366 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Propietario del 10% | 17 de noviembre de 2022 C | 888 130 | 0 | 0 | $0 |
| Adam D. Levy | — | 4 de agosto de 2026 S | 66 008 | 1 | 1 | $13 221 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 presentaciones | 23 de abril de 2026 | 28,80% | Enmienda | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.